Streamlining Anthem (Elevance Health) Ajovy Prior Authorization

Understanding Ajovy's Prior Authorization Landscape at Anthem

Ajovy (fremanezumab) is a CGRP inhibitor indicated for the preventive treatment of migraine in adults. As a high-cost specialty medication, it consistently requires prior authorization across commercial, Medicare Advantage, and Medicaid managed care plans under Anthem. Successful authorization hinges on navigating Anthem's specific medical policies, formulary requirements, and designated submission channels, which vary based on benefit design (medical vs. pharmacy).

Anthem's Channels for Ajovy Prior Authorization Submission

Anthem-licensed plans utilize distinct pathways for prior authorization requests, depending on whether Ajovy is covered under the medical or pharmacy benefit. Klivira's platform connects to these varied channels, ensuring your submissions reach the correct destination efficiently.

Key Submission Channels for Ajovy with Anthem

• **Medical Benefit:** For Ajovy administered in a clinic or covered under buy-and-bill, submissions are typically routed through Availity Essentials. X12 278 transactions are also supported via clearinghouses.
• **Pharmacy Benefit:** When Ajovy is dispensed through a retail or specialty pharmacy, prior authorizations are managed by CarelonRx, Elevance Health's in-house PBM. Submissions can be initiated via CarelonRx's provider portal or through ePA partners like CoverMyMeds and Surescripts.
• **Policy Access:** Medical policies for Ajovy are published on Anthem operating companies' provider sites, accessible via Availity. Pharmacy benefit policies are available through CarelonRx.

Ajovy Policy and Utilization Management Criteria

Anthem's medical policies and CarelonRx's formulary criteria for Ajovy typically require documentation of a migraine diagnosis, previous treatment failures with other preventive therapies (step therapy), and adherence to specific prescribing guidelines. These criteria are designed to ensure medical necessity and appropriate utilization.

Common Utilization Management Considerations for Ajovy

• **Medical Necessity:** Documentation of chronic or episodic migraine diagnosis, severity, and frequency.
• **Step Therapy:** Evidence of trials and failures or contraindications to other first-line preventive medications.
• **Quantity Limits:** Adherence to prescribed dosing and frequency as per FDA approval and payer policy.
• **Exclusion Criteria:** Verification that the patient does not have contraindications or specific conditions outlined in the policy.

Accelerating Ajovy PA Decisions with Electronic Prior Authorization (ePA)

Klivira leverages electronic prior authorization capabilities to expedite Ajovy approvals. For pharmacy benefit Ajovy, this includes integrations with industry-standard ePA platforms. For medical benefit, our EMR integration minimizes manual data entry and facilitates direct submission.

Klivira's ePA Advantages for Anthem Ajovy Requests

• **Pharmacy Benefit ePA:** Direct connectivity to CoverMyMeds and Surescripts for Ajovy requests managed by CarelonRx.
• **X12 278 Transactions:** Support for electronic submission of medical benefit PAs, reducing fax and portal-based workflows.
• **SMART on FHIR Integration:** Streamlined data exchange with your EMR, pre-populating forms and attaching clinical documentation for both medical and pharmacy benefit PAs.
• **Real-time Status Updates:** Access to current PA status directly within your workflow, reducing calls to Anthem.

Navigating Denials and Appeals for Ajovy with Anthem

Denials for Ajovy prior authorizations can stem from various issues, including insufficient clinical documentation, failure to meet step therapy requirements, or non-formulary status. Understanding Anthem's specific denial reasons and appeal pathways is critical for overturning unfavorable decisions.

Common Denial Reasons and Appeal Pathways for Ajovy

• **Insufficient Documentation:** Ensure all required clinical notes, diagnostic test results, and treatment history are submitted.
• **Step Therapy Non-Compliance:** Verify and document adherence to Anthem's step therapy protocols or provide clear rationale for exceptions.
• **Medical Necessity Not Met:** Re-evaluate clinical criteria against Anthem's policy and provide additional supporting evidence.
• **Appeal Process:** Initiate appeals through the Anthem operating company's documented appeal process, which includes options for peer-to-peer review, escalating to external review if necessary.